$AHCO
AdaptHealth Corp. Stock $ahco

$ahco Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000162828023005590 Filed on February 28, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$744.6M	$780.3M	$2.971B
YoY Change	5.44%	11.13%	21.02%
Cost Of Revenue	$655.4M	$681.9M	$2.553B
YoY Change	9.76%	17.87%	27.09%
Gross Profit	$89.23M	$98.36M	$417.4M
YoY Change	-18.2%	-20.39%	-6.32%
Gross Profit Margin	11.98%	12.61%	14.05%
Selling, General & Admin	$64.77M	$54.85M	$245.7M
YoY Change	16.08%	14.29%	4.74%
% of Gross Profit	72.59%	55.76%	58.86%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$93.81M	$102.3M	$351.2M
YoY Change	21.79%	-8.28%	36.09%
% of Gross Profit	105.14%	104.05%	84.13%
Operating Expenses	$80.30M	$71.63M	$310.6M
YoY Change	11.71%	10.07%	4.33%
Operating Profit	$26.18M	$26.73M	$190.4M
YoY Change	-49.22%	-54.29%	-15.6%
Interest Expense	$31.96M	-$30.50M	$109.4M
YoY Change	28.98%	2.37%	14.94%
% of Operating Profit	122.07%	-114.08%	57.46%
Other Income/Expense, Net	-$1.175M	$12.93M	-$253.0K
YoY Change	-79.24%	-323.05%	-86.19%
Pretax Income	$14.96M	$3.162M	$97.90M
YoY Change	-68.72%	-90.56%	-48.73%
Income Tax	-$1.700M	$4.733M	$24.77M
% Of Pretax Income	-11.36%	149.68%	25.3%
Net Earnings	$15.71M	-$2.376M	$69.32M
YoY Change	-62.38%	-110.36%	-55.62%
Net Earnings / Revenue	2.11%	-0.3%	2.33%
Basic Earnings Per Share	$0.11		$0.47
Diluted Earnings Per Share	-$0.06	-$0.02	$0.33
COMMON SHARES
Basic Shares Outstanding	135.5M shares	134.7M	134.2M shares
Diluted Shares Outstanding	136.0M shares		139.0M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$101.4M	$46.27M	$46.27M
YoY Change	-15.09%	-69.08%	-69.08%
Cash & Equivalents	$101.4M	$46.27M	$0.00
Short-Term Investments
Other Short-Term Assets	$56.08M	$52.14M	$52.14M
YoY Change	115.48%	39.25%	39.25%
Inventory	$136.0M	$127.8M	$127.8M
Prepaid Expenses
Receivables	$353.2M	$359.1M	$359.1M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$646.7M	$585.3M	$585.3M
YoY Change	5.16%	-12.65%	-12.65%
LONG-TERM ASSETS
Property, Plant & Equipment	$633.8M	$622.0M	$622.0M
YoY Change	49.22%	56.06%	13.85%
Goodwill	$3.545B	$3.545B
YoY Change	0.86%	0.93%
Intangibles	$152.8M	$162.8M
YoY Change	-20.58%	-19.51%
Long-Term Investments
YoY Change
Other Assets	$19.67M	$22.42M	$304.2M
YoY Change	29.63%	48.46%	-4.73%
Total Long-Term Assets	$4.637B	$4.634B	$4.634B
YoY Change	1.03%	1.18%	1.18%
TOTAL ASSETS
Total Short-Term Assets	$646.7M	$585.3M	$585.3M
Total Long-Term Assets	$4.637B	$4.634B	$4.634B
Total Assets	$5.283B	$5.220B	$5.220B
YoY Change	1.52%	-0.59%	-0.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$302.1M	$222.5M	$266.7M
YoY Change	41.93%	-10.29%	7.55%
Accrued Expenses	$83.78M	$100.8M	$100.8M
YoY Change	4.98%	5.07%	5.07%
Deferred Revenue	$32.41M	$31.64M
YoY Change	5.87%	0.86%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$40.00M	$35.00M	$37.21M
YoY Change	100.0%	75.0%	4.98%
Total Short-Term Liabilities	$524.5M	$456.2M	$456.2M
YoY Change	18.24%	-8.72%	-8.72%
LONG-TERM LIABILITIES
Long-Term Debt	$2.169B	$2.153B	$2.157B
YoY Change	-0.47%	-1.39%	-1.21%
Other Long-Term Liabilities	$302.9M	$305.5M	$448.4M
YoY Change	-3.53%	-5.27%	-10.37%
Total Long-Term Liabilities	$2.472B	$2.459B	$2.606B
YoY Change	-0.86%	-1.89%	-2.92%
TOTAL LIABILITIES
Total Short-Term Liabilities	$524.5M	$456.2M	$456.2M
Total Long-Term Liabilities	$2.472B	$2.459B	$2.606B
Total Liabilities	$3.116B	$3.062B	$3.068B
YoY Change	1.05%	-3.83%	-3.77%
SHAREHOLDERS EQUITY
Retained Earnings	$42.00M	$26.30M
YoY Change	-3404.64%	-161.12%
Common Stock	$13.00K	$13.00K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.160B	$2.151B	$2.151B
YoY Change
Total Liabilities & Shareholders Equity	$5.283B	$5.220B	$5.220B
YoY Change	1.52%	-0.59%	-0.59%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	$15.71M	-$2.376M	$69.32M
YoY Change	-62.38%	-110.36%	-55.62%
Depreciation, Depletion And Amortization	$93.81M	$102.3M	$351.2M
YoY Change	21.79%	-8.28%	36.09%
Cash From Operating Activities	$140.2M	$96.92M	$373.9M
YoY Change	111.05%	-3.97%	35.62%
INVESTING ACTIVITIES
Capital Expenditures	$89.12M	$142.9M	$391.4M
YoY Change	15.49%	-324.63%	92.53%
Acquisitions	$447.0K		$19.02M
YoY Change	-84.75%		-98.83%
Other Investing Activities	-$447.0K	-$2.883M	-$19.75M
YoY Change	-84.75%	-98.58%	-98.78%
Cash From Investing Activities	-$89.57M	-$145.8M	-$411.2M
YoY Change	11.82%	-45.24%	-77.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$13.99M
YoY Change			-94.98%
Debt Paid & Issued, Net	$30.00M		$20.00M
YoY Change	500.0%		-97.58%
Cash From Financing Activities	$4.448M	-15.59M	-$66.05M
YoY Change	-126.87%	-28.19%	-104.13%
NET CHANGE
Cash From Operating Activities	$140.2M	96.92M	$373.9M
Cash From Investing Activities	-$89.57M	-145.8M	-$411.2M
Cash From Financing Activities	$4.448M	-15.59M	-$66.05M
Net Change In Cash	$55.13M	-64.47M	-$103.4M
YoY Change	-282.55%	-65.53%	-308.1%
FREE CASH FLOW
Cash From Operating Activities	$140.2M	$96.92M	$373.9M
Capital Expenditures	$89.12M	$142.9M	$391.4M
Free Cash Flow	$51.13M	-$45.99M	-$17.56M
YoY Change	-577.16%	-127.95%	-124.26%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001725255
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	us-gaap	Type Of Revenue Extensible List TypeOfRevenueExtensibleList	http://fasb.org/us-gaap/2022#HealthCarePatientServiceMember
CY2021	us-gaap	Type Of Revenue Extensible List TypeOfRevenueExtensibleList	http://fasb.org/us-gaap/2022#HealthCarePatientServiceMember
CY2020	us-gaap	Type Of Revenue Extensible List TypeOfRevenueExtensibleList	http://fasb.org/us-gaap/2022#HealthCarePatientServiceMember
CY2021	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://fasb.org/us-gaap/2022#HealthCarePatientServiceMember
CY2020	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://fasb.org/us-gaap/2022#HealthCarePatientServiceMember
CY2022	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://fasb.org/us-gaap/2022#HealthCarePatientServiceMember
CY2022	us-gaap	Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
CY2020	us-gaap	Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
CY2021	us-gaap	Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
CY2020Q3	ahco	Warrant Redemption Threshold Consecutive Trading Days WarrantRedemptionThresholdConsecutiveTradingDays	P30D
CY2020Q3	ahco	Business Combination Contingent Consideration Period For Measurement Of Hurdle BusinessCombinationContingentConsiderationPeriodForMeasurementOfHurdle	P10D
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-38399
CY2022	dei	Entity Registrant Name EntityRegistrantName	AdaptHealth Corp.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-3677704
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	220 West Germantown Pike
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 250
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Plymouth Meeting
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	PA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	19462
CY2022	dei	City Area Code CityAreaCode	610
CY2022	dei	Local Phone Number LocalPhoneNumber	424-4515
CY2022	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2022	dei	Trading Symbol TradingSymbol	AHCO
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	false
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	1510000000	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	135451062	shares
CY2022	dei	Auditor Name AuditorName	KPMG LLP
CY2022	dei	Auditor Location AuditorLocation	Philadelphia, Pennsylvania
CY2022	dei	Auditor Firm AuditorFirmId	185
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	46272000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	149627000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	359146000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	359896000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	127754000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	123095000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	52136000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	37440000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	585308000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	670058000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	487079000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	398577000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	129506000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	147760000	usd
CY2022Q4	ahco	Finance Lease Right Of Use Asset After Accumulated Amortization Excluding Portion Within Equipment And Other Fixed Assets Net FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationExcludingPortionWithinEquipmentAndOtherFixedAssetsNet	5423000	usd
CY2021Q4	ahco	Finance Lease Right Of Use Asset After Accumulated Amortization Excluding Portion Within Equipment And Other Fixed Assets Net FinanceLeaseRightOfUseAssetAfterAccumulatedAmortizationExcludingPortionWithinEquipmentAndOtherFixedAssetsNet	0	usd
CY2022Q4	us-gaap	Goodwill Goodwill	3545297000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	3512567000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	162773000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	202231000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	22415000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	15098000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	281786000	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	304193000	usd
CY2022Q4	us-gaap	Assets Assets	5219587000	usd
CY2021Q4	us-gaap	Assets Assets	5250484000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	337498000	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	358384000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	35000000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	20000000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	30001000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	31418000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2211000	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	15446000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	31641000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	31370000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	19863000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	43194000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	456214000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	499812000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2153267000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2183552000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	104394000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	120180000	usd
CY2022Q4	ahco	Finance Lease Liability Noncurrent Excluding Portion Within Other Liabilities Noncurrent FinanceLeaseLiabilityNoncurrentExcludingPortionWithinOtherLiabilitiesNoncurrent	3950000	usd
CY2021Q4	ahco	Finance Lease Liability Noncurrent Excluding Portion Within Other Liabilities Noncurrent FinanceLeaseLiabilityNoncurrentExcludingPortionWithinOtherLiabilitiesNoncurrent	0	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	305501000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	322487000	usd
CY2022Q4	ahco	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	38503000	usd
CY2021Q4	ahco	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	57764000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3061829000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	3183795000	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	134435119	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	134435119	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	133843732	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	133843732	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	13000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	13000	usd
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	124060	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	124060	shares
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	1000	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	1000	usd
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	750835	shares
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	13992000	usd
CY2021Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	0	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2130148000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2107267000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	26295000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-43021000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	8693000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2354000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	2151158000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	2061906000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	6600000	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	4783000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2157758000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2066689000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5219587000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5250484000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2970595000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2454535000	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1056389000	usd
CY2022	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	0	usd
CY2021	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	10595000	usd
CY2020	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	14277000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2553169000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2008925000	usd
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	898601000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	162125000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	167505000	usd
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	89346000	usd
CY2022	ahco	Depreciation Expense Excluding Patient Equipment Depreciation DepreciationExpenseExcludingPatientEquipmentDepreciation	64890000	usd
CY2021	ahco	Depreciation Expense Excluding Patient Equipment Depreciation DepreciationExpenseExcludingPatientEquipmentDepreciation	63095000	usd
CY2020	ahco	Depreciation Expense Excluding Patient Equipment Depreciation DepreciationExpenseExcludingPatientEquipmentDepreciation	11373000	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	2780184000	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	2239525000	usd
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	999320000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	190411000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	225605000	usd
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	71346000	usd
CY2022	us-gaap	Interest Expense InterestExpense	109414000	usd
CY2021	us-gaap	Interest Expense InterestExpense	95195000	usd
CY2020	us-gaap	Interest Expense InterestExpense	41430000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-17158000	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-53181000	usd
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	135368000	usd
CY2022	ahco	Increase Decrease In Fair Value Of Earn Out Contingent Consideration IncreaseDecreaseInFairValueOfEarnOutContingentConsideration	0	usd
CY2021	ahco	Increase Decrease In Fair Value Of Earn Out Contingent Consideration IncreaseDecreaseInFairValueOfEarnOutContingentConsideration	-29389000	usd
CY2020	ahco	Increase Decrease In Fair Value Of Earn Out Contingent Consideration IncreaseDecreaseInFairValueOfEarnOutContingentConsideration	98717000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-20189000	usd
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-5316000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-253000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1832000	usd
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3444000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	97902000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	190959000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-206041000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24769000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	32806000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-11955000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	73133000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	158153000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	-194086000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	3817000	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1978000	usd
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-32454000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	69316000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	156175000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-161632000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	134175000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	126306000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	52488000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	138988000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	133034000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52488000	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.47
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.12
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.08
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.33
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.67
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.08
CY2022	us-gaap	Profit Loss ProfitLoss	73133000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	158153000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	-194086000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	11047000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	5776000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-10667000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	84180000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	163929000	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-204753000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	3817000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1978000	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-32454000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	80363000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	161951000	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-172299000	usd
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-65783000	usd
CY2020	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	123887000	usd
CY2020	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	44273000	usd
CY2020	ahco	Warrants Exercised Value WarrantsExercisedValue	24495000	usd
CY2020	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	49098000	usd
CY2020	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	18670000	usd
CY2020	ahco	Adjustments To Additional Paid In Capital Shares Issued In Satisfaction Of Contingent Consideration Liability Value AdjustmentsToAdditionalPaidInCapitalSharesIssuedInSatisfactionOfContingentConsiderationLiabilityValue	37556000	usd
CY2020	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	800000	usd
CY2020	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	101000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	-194086000	usd
CY2020	ahco	Adjustments To Additional Paid In Capital Tax Receivable Agreement AdjustmentsToAdditionalPaidInCapitalTaxReceivableAgreement	24787000	usd
CY2020	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-8088000	usd
CY2020	ahco	Adjustments To Additional Paid In Capital Put Call Agreement AdjustmentsToAdditionalPaidInCapitalPutCallAgreement	-29927000	usd
CY2020	us-gaap	Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1	-10667000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	280845000	usd
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	602661000	usd
CY2021	ahco	Stock Options Issued During Period Value Acquisitions StockOptionsIssuedDuringPeriodValueAcquisitions	134683000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2960000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12320000	usd
CY2021	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	25323000	usd
CY2021	ahco	Adjustments To Additional Paid In Capital Shares Issued In Satisfaction Of Contingent Consideration Liability Value AdjustmentsToAdditionalPaidInCapitalSharesIssuedInSatisfactionOfContingentConsiderationLiabilityValue	41088000	usd
CY2021	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	1070000	usd
CY2021	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1016000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	158153000	usd
CY2021	ahco	Adjustments To Additional Paid In Capital Tax Receivable Agreement AdjustmentsToAdditionalPaidInCapitalTaxReceivableAgreement	17617000	usd
CY2021	us-gaap	Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1	5776000	usd
CY2021	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	3557000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2066689000	usd
CY2022	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	22397000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2510000	usd
CY2022	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	4142000	usd
CY2022	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	13992000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2103000	usd
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1616000	usd
CY2022	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	2000000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	73133000	usd
CY2022	ahco	Adjustments To Additional Paid In Capital Deferred Tax Impact Relating To Contingent Consideration Common Shares Value AdjustmentsToAdditionalPaidInCapitalDeferredTaxImpactRelatingToContingentConsiderationCommonSharesValue	1603000	usd
CY2022	us-gaap	Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1	11047000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2157758000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	73133000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	158153000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	-194086000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	351178000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	258053000	usd
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	82445000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	22397000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	25323000	usd
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	18670000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-17158000	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-53181000	usd
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	135368000	usd
CY2022	ahco	Increase Decrease In Fair Value Of Earn Out Contingent Consideration IncreaseDecreaseInFairValueOfEarnOutContingentConsideration	0	usd
CY2021	ahco	Increase Decrease In Fair Value Of Earn Out Contingent Consideration IncreaseDecreaseInFairValueOfEarnOutContingentConsideration	-29389000	usd
CY2020	ahco	Increase Decrease In Fair Value Of Earn Out Contingent Consideration IncreaseDecreaseInFairValueOfEarnOutContingentConsideration	98717000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	32264000	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	28624000	usd
CY2020	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	18036000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	22380000	usd
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-21101000	usd
CY2022	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	2936000	usd
CY2021	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	2927000	usd
CY2020	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	2845000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	5234000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	5378000	usd
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1876000	usd
CY2022	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	0	usd
CY2021	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	4054000	usd
CY2020	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	5316000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost	0	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost	-16135000	usd
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt Before Write Off Of Deferred Debt Issuance Cost GainsLossesOnExtinguishmentOfDebtBeforeWriteOffOfDeferredDebtIssuanceCost	0	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	285000	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	3615000	usd
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	5636000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	209000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	29694000	usd
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	29517000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6300000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	14920000	usd
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	19434000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	13143000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2731000	usd
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	10767000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-31213000	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-28043000	usd
CY2020	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-57131000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-83383000	usd
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	136628000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	373867000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	275679000	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	195634000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	19017000	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1620320000	usd
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	769337000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	391423000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	203308000	usd
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	39755000	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	731000	usd
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	1125000	usd
CY2020	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	8657000	usd
CY2022	us-gaap	Proceeds From Sale Of Trading Securities Heldforinvestment ProceedsFromSaleOfTradingSecuritiesHeldforinvestment	0	usd
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2021	us-gaap	Proceeds From Sale Of Trading Securities Heldforinvestment ProceedsFromSaleOfTradingSecuritiesHeldforinvestment	0	usd
CY2020	us-gaap	Proceeds From Sale Of Trading Securities Heldforinvestment ProceedsFromSaleOfTradingSecuritiesHeldforinvestment	2046000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-411171000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1824753000	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-815703000	usd
CY2022	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
CY2021	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1165000000	usd
CY2020	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	591275000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	20000000	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	827271000	usd
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	547480000	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	16176000	usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	42164000	usd
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	39051000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	13992000	usd
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2510000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	12320000	usd
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2022	us-gaap	Proceeds From Repayment Of Loans By Employee Stock Ownership Plans ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans	1616000	usd
CY2021	us-gaap	Proceeds From Repayment Of Loans By Employee Stock Ownership Plans ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans	1016000	usd
CY2020	us-gaap	Proceeds From Repayment Of Loans By Employee Stock Ownership Plans ProceedsFromRepaymentOfLoansByEmployeeStockOwnershipPlans	101000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3516000	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3557000	usd
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	59000	usd
CY2022	ahco	Payments For Contingent Consideration Liability And Deferred Purchase Price From Acquisitions PaymentsForContingentConsiderationLiabilityAndDeferredPurchasePriceFromAcquisitions	14493000	usd
CY2021	ahco	Payments For Contingent Consideration Liability And Deferred Purchase Price From Acquisitions PaymentsForContingentConsiderationLiabilityAndDeferredPurchasePriceFromAcquisitions	25233000	usd
CY2020	ahco	Payments For Contingent Consideration Liability And Deferred Purchase Price From Acquisitions PaymentsForContingentConsiderationLiabilityAndDeferredPurchasePriceFromAcquisitions	3954000	usd
CY2022	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	2000000	usd
CY2021	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	1070000	usd
CY2020	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	800000	usd
CY2022	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	1100000000	usd
CY2020	us-gaap	Proceeds From Issuance Of Unsecured Debt ProceedsFromIssuanceOfUnsecuredDebt	350000000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	278850000	usd
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	142600000	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	13832000	usd
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	11725000	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	usd
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	29185000	usd
CY2020	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	13049000	usd
CY2022	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
CY2021	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	16135000	usd
CY2020	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
CY2020	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	225000000	usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	24495000	usd
CY2022	ahco	Payments For Exchange Of Common Stock For Cash PaymentsForExchangeOfCommonStockForCash	0	usd
CY2021	ahco	Payments For Exchange Of Common Stock For Cash PaymentsForExchangeOfCommonStockForCash	0	usd
CY2020	ahco	Payments For Exchange Of Common Stock For Cash PaymentsForExchangeOfCommonStockForCash	44273000	usd
CY2022	ahco	Payments For Exercise Of Call Option Relating To Put Call Agreement PaymentsForExerciseOfCallOptionRelatingToPutCallAgreement	0	usd
CY2021	ahco	Payments For Exercise Of Call Option Relating To Put Call Agreement PaymentsForExerciseOfCallOptionRelatingToPutCallAgreement	0	usd
CY2020	ahco	Payments For Exercise Of Call Option Relating To Put Call Agreement PaymentsForExerciseOfCallOptionRelatingToPutCallAgreement	29927000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-66051000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1598739000	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	643153000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-103355000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	49665000	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	23084000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	149627000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99962000	usd
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	76878000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	46272000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	149627000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99962000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	108885000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	73630000	usd
CY2020	us-gaap	Interest Paid Net InterestPaidNet	35771000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	14949000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	14792000	usd
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	7480000	usd
CY2022	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	1335000	usd
CY2021	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	22959000	usd
CY2020	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	40012000	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	24221000	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	13936000	usd
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	7869000	usd
CY2022	ahco	Assets Obtained In Exchange For Operating Lease Obligations Excluding Those Attributable To Business Combinations AssetsObtainedInExchangeForOperatingLeaseObligationsExcludingThoseAttributableToBusinessCombinations	22543000	usd
CY2021	ahco	Assets Obtained In Exchange For Operating Lease Obligations Excluding Those Attributable To Business Combinations AssetsObtainedInExchangeForOperatingLeaseObligationsExcludingThoseAttributableToBusinessCombinations	12777000	usd
CY2020	ahco	Assets Obtained In Exchange For Operating Lease Obligations Excluding Those Attributable To Business Combinations AssetsObtainedInExchangeForOperatingLeaseObligationsExcludingThoseAttributableToBusinessCombinations	0	usd
CY2022	ahco	Operating Lease Obligation Incurred In Exchange For Operating Lease Right Of Use Assets Additions OperatingLeaseObligationIncurredInExchangeForOperatingLeaseRightOfUseAssetsAdditions	22543000	usd
CY2021	ahco	Operating Lease Obligation Incurred In Exchange For Operating Lease Right Of Use Assets Additions OperatingLeaseObligationIncurredInExchangeForOperatingLeaseRightOfUseAssetsAdditions	12777000	usd
CY2020	ahco	Operating Lease Obligation Incurred In Exchange For Operating Lease Right Of Use Assets Additions OperatingLeaseObligationIncurredInExchangeForOperatingLeaseRightOfUseAssetsAdditions	0	usd
CY2022	ahco	Assets Written Off Subject To Operating Lease Obligations AssetsWrittenOffSubjectToOperatingLeaseObligations	8532000	usd
CY2021	ahco	Assets Written Off Subject To Operating Lease Obligations AssetsWrittenOffSubjectToOperatingLeaseObligations	0	usd
CY2020	ahco	Assets Written Off Subject To Operating Lease Obligations AssetsWrittenOffSubjectToOperatingLeaseObligations	0	usd
CY2022	ahco	Liabilities Written Off Operating Lease Obligations LiabilitiesWrittenOffOperatingLeaseObligations	8532000	usd
CY2021	ahco	Liabilities Written Off Operating Lease Obligations LiabilitiesWrittenOffOperatingLeaseObligations	0	usd
CY2020	ahco	Liabilities Written Off Operating Lease Obligations LiabilitiesWrittenOffOperatingLeaseObligations	0	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	0	usd
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	1261200000	usd
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	123887000	usd
CY2022	ahco	Noncash Or Part Noncash Acquisition Contingent Purchase Price NoncashOrPartNoncashAcquisitionContingentPurchasePrice	0	usd
CY2021	ahco	Noncash Or Part Noncash Acquisition Contingent Purchase Price NoncashOrPartNoncashAcquisitionContingentPurchasePrice	7800000	usd
CY2020	ahco	Noncash Or Part Noncash Acquisition Contingent Purchase Price NoncashOrPartNoncashAcquisitionContingentPurchasePrice	27064000	usd
CY2022	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	457000	usd
CY2021	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	4478000	usd
CY2020	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	33000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	Accounting EstimatesThe preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and reported amounts of revenues and expenses during the reporting period. Management bases these estimates and assumptions upon historical experience, existing and known circumstances, authoritative accounting pronouncements and other factors that management believes to be reasonable. Significant areas requiring the use of management estimates relate to revenue recognition and the valuation of accounts receivable (implicit price concession), income taxes, equity-based compensation, warrant liability and long-lived assets, including goodwill and identifiable intangible assets. Actual results could differ from those estimates.
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2970595000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2454535000	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1056389000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2970595000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2454535000	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1056389000	usd
CY2022Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	38600000	usd
CY2021Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	23800000	usd
CY2020Q2	ahco	Proceeds From Government Assistance ProceedsFromGovernmentAssistance	17200000	usd
CY2021	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	10600000	usd
CY2020	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	14300000	usd
CY2020Q2	ahco	Cares Act Recoupable Advance Payment CaresActRecoupableAdvancePayment	45800000	usd
CY2022	ahco	Cares Act Recoupment Of Advance Payment CaresActRecoupmentOfAdvancePayment	12800000	usd
CY2021	ahco	Cares Act Recoupment Of Advance Payment CaresActRecoupmentOfAdvancePayment	36700000	usd
	ahco	Social Security Tax Employer Deferral Cares Act SocialSecurityTaxEmployerDeferralCaresAct	8600000	usd
CY2022Q1	ahco	Payment Of Deferred Employment Tax PaymentOfDeferredEmploymentTax	4300000	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2022Q4	ahco	Payment Of Deferred Employment Tax PaymentOfDeferredEmploymentTax	4300000	usd
CY2022Q4	us-gaap	Cash Cash	46272000	usd
CY2021Q4	us-gaap	Cash Cash	149613000	usd
CY2022Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	0	usd
CY2021Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	14000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	46272000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	149627000	usd
CY2020	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	19200000	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	18500000	usd
CY2020	us-gaap	Advertising Expense AdvertisingExpense	5300000	usd
CY2022	us-gaap	Cost Direct Material CostDirectMaterial	1199481000	usd
CY2021	us-gaap	Cost Direct Material CostDirectMaterial	955813000	usd
CY2020	us-gaap	Cost Direct Material CostDirectMaterial	441931000	usd
CY2022	us-gaap	Cost Direct Labor CostDirectLabor	770669000	usd
CY2021	us-gaap	Cost Direct Labor CostDirectLabor	595668000	usd
CY2020	us-gaap	Cost Direct Labor CostDirectLabor	257898000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	286288000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	194958000	usd
CY2020	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	71072000	usd
CY2022	us-gaap	Occupancy Net OccupancyNet	64375000	usd
CY2021	us-gaap	Occupancy Net OccupancyNet	48586000	usd
CY2020	us-gaap	Occupancy Net OccupancyNet	22344000	usd
CY2022	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	225719000	usd
CY2021	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	206599000	usd
CY2020	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	97511000	usd
CY2022	ahco	Share Based Compensation Expense Direct Cost ShareBasedCompensationExpenseDirectCost	6637000	usd
CY2021	ahco	Share Based Compensation Expense Direct Cost ShareBasedCompensationExpenseDirectCost	7301000	usd
CY2020	ahco	Share Based Compensation Expense Direct Cost ShareBasedCompensationExpenseDirectCost	7845000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	2553169000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	2008925000	usd
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	898601000	usd
CY2022	us-gaap	Labor And Related Expense LaborAndRelatedExpense	60600000	usd
CY2021	us-gaap	Labor And Related Expense LaborAndRelatedExpense	60100000	usd
CY2020	us-gaap	Labor And Related Expense LaborAndRelatedExpense	35800000	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Concentration of Credit RiskFinancial instruments which potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and trade accounts receivable. The Company maintains its cash in bank deposit accounts, which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant credit risk on cash and cash equivalents. As of December 31, 2022 and 2021, less than 10% of the Company’s net accounts receivable are from patients under co-pay or private plan arrangements.
CY2022	us-gaap	Business Combination Pro Forma Information Revenue Of Acquiree Since Acquisition Date Actual BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual	16455000	usd
CY2021	us-gaap	Business Combination Pro Forma Information Revenue Of Acquiree Since Acquisition Date Actual BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual	1005097000	usd
CY2020	us-gaap	Business Combination Pro Forma Information Revenue Of Acquiree Since Acquisition Date Actual BusinessCombinationProFormaInformationRevenueOfAcquireeSinceAcquisitionDateActual	427352000	usd
CY2022	us-gaap	Business Combination Pro Forma Information Earnings Or Loss Of Acquiree Since Acquisition Date Actual BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual	767000	usd
CY2021	us-gaap	Business Combination Pro Forma Information Earnings Or Loss Of Acquiree Since Acquisition Date Actual BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual	136404000	usd
CY2020	us-gaap	Business Combination Pro Forma Information Earnings Or Loss Of Acquiree Since Acquisition Date Actual BusinessCombinationProFormaInformationEarningsOrLossOfAcquireeSinceAcquisitionDateActual	17673000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	870267000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	620181000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	383188000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	221604000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	487079000	usd
CY2021Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	398577000	usd
CY2022	us-gaap	Depreciation Depreciation	311200000	usd
CY2021	us-gaap	Depreciation Depreciation	211500000	usd
CY2020	us-gaap	Depreciation Depreciation	76400000	usd
CY2022	ahco	Property Plant And Equipment Fully Depreciated Assets Written Off PropertyPlantAndEquipmentFullyDepreciatedAssetsWrittenOff	275100000	usd
CY2021	ahco	Property Plant And Equipment Fully Depreciated Assets Written Off PropertyPlantAndEquipmentFullyDepreciatedAssetsWrittenOff	71900000	usd
CY2020	ahco	Property Plant And Equipment Fully Depreciated Assets Written Off PropertyPlantAndEquipmentFullyDepreciatedAssetsWrittenOff	62600000	usd
CY2020Q4	us-gaap	Goodwill Goodwill	998810000	usd
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	2536566000	usd
CY2021	us-gaap	Business Combination Provisional Information Initial Accounting Incomplete Adjustments Related To Previous Period BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod	-657000	usd
CY2021	us-gaap	Goodwill Other Increase Decrease GoodwillOtherIncreaseDecrease	-22152000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	3512567000	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	12341000	usd
CY2022	us-gaap	Business Combination Provisional Information Initial Accounting Incomplete Adjustments Related To Previous Period BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsRelatedToPreviousPeriod	2009000	usd
CY2022	us-gaap	Goodwill Other Increase Decrease GoodwillOtherIncreaseDecrease	18380000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	3545297000	usd
CY2022Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths	32613000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022	us-gaap	Goodwill Other Increase Decrease GoodwillOtherIncreaseDecrease	18400000	usd
CY2022	us-gaap	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Financial Assets BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancialAssets	-900000	usd
CY2022	us-gaap	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Property Plant And Equipment BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentPropertyPlantAndEquipment	-10000000	usd
CY2022	ahco	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Current Liabilities Other BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCurrentLiabilitiesOther	7300000	usd
CY2022	ahco	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Accounts Payable And Accrued Liabilities Current BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilitiesCurrent	-2200000	usd
CY2022	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	16000000	usd
CY2021	us-gaap	Goodwill Other Increase Decrease GoodwillOtherIncreaseDecrease	-22200000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	162773000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	202231000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	40000000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	46500000	usd
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6000000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	22276000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	21328000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour	19263000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFive	17960000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseRollingAfterYearFive	49333000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	162773000	usd
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2020	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	20300000	usd
CY2022	ahco	Contingent Consideration Liability Additions ContingentConsiderationLiabilityAdditions	0	usd
CY2022	ahco	Payment For Contingent Consideration Liability PaymentForContingentConsiderationLiability	15015000	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-2215000	usd
CY2022	ahco	Business Combination Contingent Consideration Liability Other Activity BusinessCombinationContingentConsiderationLiabilityOtherActivity	0	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	7500000	usd
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	33540000	usd
CY2021	ahco	Contingent Consideration Liability Additions ContingentConsiderationLiabilityAdditions	7800000	usd
CY2021	ahco	Payment For Contingent Consideration Liability PaymentForContingentConsiderationLiability	20347000	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	866000	usd
CY2021	ahco	Business Combination Contingent Consideration Liability Other Activity BusinessCombinationContingentConsiderationLiabilityOtherActivity	173000	usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	20300000	usd
CY2022Q4	us-gaap	Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet	7600000	usd
CY2021Q4	us-gaap	Derivative Liability Notional Amount DerivativeLiabilityNotionalAmount	250000000	usd
CY2022Q4	us-gaap	Derivative Liability Notional Amount DerivativeLiabilityNotionalAmount	250000000	usd
CY2021Q4	us-gaap	Derivative Liability Notional Amount DerivativeLiabilityNotionalAmount	250000000	usd
CY2022Q4	us-gaap	Derivative Liability Notional Amount DerivativeLiabilityNotionalAmount	250000000	usd
CY2022	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	2900000	usd
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	8700000	usd
CY2021	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	2900000	usd
CY2020	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-7800000	usd
CY2020	us-gaap	Reclassification From Aoci Current Period Before Tax Attributable To Parent ReclassificationFromAociCurrentPeriodBeforeTaxAttributableToParent	2800000	usd
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	33463000	usd
CY2020Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	13710000	usd
CY2022	ahco	Capitalized Fees Deferred Finance Costs CapitalizedFeesDeferredFinanceCosts	0	usd
CY2021	ahco	Capitalized Fees Deferred Finance Costs CapitalizedFeesDeferredFinanceCosts	29185000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	5234000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	5378000	usd
CY2022	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	0	usd
CY2021	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	4054000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	28229000	usd
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	33463000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	5200000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	5400000	usd
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1900000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	28200000	usd
CY2022Q4	ahco	Deferred Financing Costs Expected Amortization Year One DeferredFinancingCostsExpectedAmortizationYearOne	5234000	usd
CY2022Q4	ahco	Deferred Financing Costs Expected Amortization Year Two DeferredFinancingCostsExpectedAmortizationYearTwo	5234000	usd
CY2022Q4	ahco	Deferred Financing Costs Expected Amortization Year Three DeferredFinancingCostsExpectedAmortizationYearThree	5147000	usd
CY2022Q4	ahco	Deferred Financing Costs Expected Amortization Year Four DeferredFinancingCostsExpectedAmortizationYearFour	3659000	usd
CY2022Q4	ahco	Deferred Financing Costs Expected Amortization Year Five DeferredFinancingCostsExpectedAmortizationYearFive	3577000	usd
CY2022Q4	ahco	Deferred Financing Costs Expected Amortization After Year Five DeferredFinancingCostsExpectedAmortizationAfterYearFive	5378000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	28229000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	222505000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	248027000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	41872000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	34370000	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	28877000	usd
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	30103000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	44244000	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	45884000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	337498000	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	358384000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	26733000	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	31448000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	2188267000	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	2203552000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	35000000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	20000000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2153267000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2183552000	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	112400000	usd
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	97900000	usd
CY2020	us-gaap	Interest Expense Debt InterestExpenseDebt	42000000	usd
CY2020Q2	ahco	Put Call Option And Consent Agreement Number Of Shares Comprising Consideration Unit PutCallOptionAndConsentAgreementNumberOfSharesComprisingConsiderationUnit	1	shares
CY2019Q4	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	1
CY2020Q4	ahco	Number Of Shares Potentially Put Or Called NumberOfSharesPotentiallyPutOrCalled	1898967	shares
CY2020Q4	ahco	Shares Put Agreement Minimum Fixed Price SharesPutAgreementMinimumFixedPrice	14.50
CY2020Q4	ahco	Shares Put Agreement Minimum Variable Price SharesPutAgreementMinimumVariablePrice	0.85
CY2020Q4	ahco	Number Of Shares Potentially Put Or Called NumberOfSharesPotentiallyPutOrCalled	1898967	shares
CY2020Q4	ahco	Shares Call Agreement Price SharesCallAgreementPrice	15.76
CY2020	ahco	Adjustments To Additional Paid In Capital Put Call Agreement AdjustmentsToAdditionalPaidInCapitalPutCallAgreement	-29900000	usd
CY2020Q4	ahco	Number Of Shares Potentially Put Or Called NumberOfSharesPotentiallyPutOrCalled	1898967	shares
CY2020Q4	ahco	Adjustments To Additional Paid In Capital Put Call Agreement AdjustmentsToAdditionalPaidInCapitalPutCallAgreement	-29900000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	35000000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	40000000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	40000000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	650000000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	1450000000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2215000000	usd
CY2021	ahco	Shares Issued During Period Value Shares Exchanged SharesIssuedDuringPeriodValueSharesExchanged	77900000	usd
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	245000000	shares
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2019Q4	ahco	Number Of Votes Per Share NumberOfVotesPerShare	1	vote
CY2022Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	200000000	usd
CY2019Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	12666666	shares
CY2019Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2019Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2022	ahco	Warrants Exercised In Cashless Transaction Number Of Warrants WarrantsExercisedInCashlessTransactionNumberOfWarrants	184870	shares
CY2022	ahco	Cashless Exercise Of Warrants Shares CashlessExerciseOfWarrantsShares	87553	shares
CY2021	ahco	Warrants Exercised In Cashless Transaction Number Of Warrants WarrantsExercisedInCashlessTransactionNumberOfWarrants	224121	shares
CY2021	ahco	Cashless Exercise Of Warrants Shares CashlessExerciseOfWarrantsShares	118379	shares
CY2020	ahco	Warrants Exercised In Cashless Transaction Number Of Warrants WarrantsExercisedInCashlessTransactionNumberOfWarrants	6254803	shares
CY2020	ahco	Warrants Exercised For Cash Number Of Warrants WarrantsExercisedForCashNumberOfWarrants	2131315	shares
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	24500000	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	3871557	shares
CY2020Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2020Q3	ahco	Warrant Cashless Exercise Share Equivalent Of Exercise Price WarrantCashlessExerciseShareEquivalentOfExercisePrice	0.6144	shares
CY2019Q4	ahco	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	27635000	usd
CY2020	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	135368000	usd
CY2020	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	49098000	usd
CY2020Q4	ahco	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	113905000	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-53181000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2960000	usd
CY2021Q4	ahco	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	57764000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-17158000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2103000	usd
CY2022Q4	ahco	Warrant Liability Noncurrent WarrantLiabilityNoncurrent	38503000	usd
CY2020Q3	ahco	Warrant Redemption Price WarrantRedemptionPrice	0.01
CY2020Q3	ahco	Warrant Redemption Stock Price Trigger WarrantRedemptionStockPriceTrigger	18.00
CY2020Q3	ahco	Warrant Redemption Threshold Trading Days WarrantRedemptionThresholdTradingDays	20	usd
CY2020Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2020Q3	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	0.3856	shares
CY2020Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2020Q3	us-gaap	Share Price SharePrice	18.7175
CY2020Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2020	ahco	Public Warrants Number Redeemed PublicWarrantsNumberRedeemed	2285410	shares
CY2020	ahco	Warrants Exercise Shares WarrantsExerciseShares	881239	shares
CY2022	ahco	Business Combination Contingent Consideration Shares Authorized Per Installment BusinessCombinationContingentConsiderationSharesAuthorizedPerInstallment	1000000	shares
CY2020	ahco	Business Combination Contingent Consideration Shares Authorized Per Installment BusinessCombinationContingentConsiderationSharesAuthorizedPerInstallment	1000000	shares
CY2021	ahco	Business Combination Contingent Consideration Shares Authorized Per Installment BusinessCombinationContingentConsiderationSharesAuthorizedPerInstallment	1000000	shares
CY2022	ahco	Business Combination Contingent Consideration Stock Price Hurdle Second Measurement Date BusinessCombinationContingentConsiderationStockPriceHurdleSecondMeasurementDate	22
CY2021	ahco	Business Combination Contingent Consideration Stock Price Hurdle Second Measurement Date BusinessCombinationContingentConsiderationStockPriceHurdleSecondMeasurementDate	18
CY2020	ahco	Business Combination Contingent Consideration Stock Price Hurdle Second Measurement Date BusinessCombinationContingentConsiderationStockPriceHurdleSecondMeasurementDate	15
CY2020	ahco	Business Combination Contingent Consideration Number Of Shares Issued During Period BusinessCombinationContingentConsiderationNumberOfSharesIssuedDuringPeriod	1000000	shares
CY2021	ahco	Business Combination Contingent Consideration Number Of Shares Issued During Period BusinessCombinationContingentConsiderationNumberOfSharesIssuedDuringPeriod	1000000	shares
CY2022	ahco	Business Combination Contingent Consideration Number Of Shares Issued During Period BusinessCombinationContingentConsiderationNumberOfSharesIssuedDuringPeriod	0	shares
CY2020	ahco	Business Combination Contingent Consideration Number Of Shares Issued During Period BusinessCombinationContingentConsiderationNumberOfSharesIssuedDuringPeriod	1000000	shares
CY2021	ahco	Business Combination Contingent Consideration Number Of Shares Issued During Period BusinessCombinationContingentConsiderationNumberOfSharesIssuedDuringPeriod	1000000	shares
CY2021	ahco	Business Combination Contingent Consideration Remaining Shares Reclassified To Stockholders Equity BusinessCombinationContingentConsiderationRemainingSharesReclassifiedToStockholdersEquity	1000000	shares
CY2021Q4	ahco	Business Combination Contingent Consideration Deferred Tax Asset BusinessCombinationContingentConsiderationDeferredTaxAsset	1600000	usd
CY2022Q4	ahco	Business Combination Contingent Consideration Deferred Tax Asset BusinessCombinationContingentConsiderationDeferredTaxAsset	-1600000	usd
CY2019Q4	ahco	Earn Out Contingent Liability EarnOutContingentLiability	9316000	usd
CY2020	ahco	Increase Decrease In Fair Value Of Earn Out Contingent Consideration IncreaseDecreaseInFairValueOfEarnOutContingentConsideration	98717000	usd
CY2020	ahco	Adjustments To Additional Paid In Capital Shares Issued In Satisfaction Of Contingent Consideration Liability Value AdjustmentsToAdditionalPaidInCapitalSharesIssuedInSatisfactionOfContingentConsiderationLiabilityValue	37556000	usd
CY2020Q4	ahco	Earn Out Contingent Liability EarnOutContingentLiability	70477000	usd
CY2021	ahco	Increase Decrease In Fair Value Of Earn Out Contingent Consideration IncreaseDecreaseInFairValueOfEarnOutContingentConsideration	-29389000	usd
CY2021	ahco	Adjustments To Additional Paid In Capital Shares Issued In Satisfaction Of Contingent Consideration Liability Value AdjustmentsToAdditionalPaidInCapitalSharesIssuedInSatisfactionOfContingentConsiderationLiabilityValue	41088000	usd
CY2021Q4	ahco	Earn Out Contingent Liability EarnOutContingentLiability	0	usd
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	703170	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P3Y
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P5Y
CY2021Q1	ahco	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue	6900000	usd
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3416666	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	11.50
CY2019Q4	ahco	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue	7200000	usd
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	47335	shares
CY2020Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	16.25
CY2020Q2	ahco	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateFairValue	300000	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3464001	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3417000	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.50
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	47000	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	16.25
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3464000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.56
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	703000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	48.72
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1447000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	10.16
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	914000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	11.66
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5766000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	11.26
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	804000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.69
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4962000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.19
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y7M6D
CY2022	ahco	Stock Issued During Period Shares Stock Options Exercised Cash Basis StockIssuedDuringPeriodSharesStockOptionsExercisedCashBasis	489191	shares
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2500000	usd
CY2022	ahco	Stock Issued During Period Shares Stock Options Exercised Cash Basis StockIssuedDuringPeriodSharesStockOptionsExercisedCashBasis	489191	shares
CY2022	ahco	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Cashless Basis ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodCashlessBasis	315349	shares
CY2022	ahco	Stock Issued During Period Stock Options Exercised Cashless Basis Shares StockIssuedDuringPeriodStockOptionsExercisedCashlessBasisShares	131741	shares
CY2021	ahco	Stock Issued During Period Shares Stock Options Exercised Cash Basis StockIssuedDuringPeriodSharesStockOptionsExercisedCashBasis	1138982	shares
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12300000	usd
CY2021	ahco	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Cashless Basis ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodCashlessBasis	307613	shares
CY2021	ahco	Stock Issued During Period Stock Options Exercised Cashless Basis Shares StockIssuedDuringPeriodStockOptionsExercisedCashlessBasisShares	133126	shares
CY2020	ahco	Stock Issued During Period Shares Stock Options Exercised Cash Basis StockIssuedDuringPeriodSharesStockOptionsExercisedCashBasis	0	shares
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	22400000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	2100000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	25300000	usd
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	4600000	usd
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18700000	usd
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	2100000	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	34400000	usd
CY2022	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y10M24D
CY2022	us-gaap	Net Income Loss NetIncomeLoss	69316000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	156175000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-161632000	usd
CY2022	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	5867000	usd
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1500000	usd
CY2021	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	14379000	usd
CY2020	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	63449000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	141796000	usd
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-161632000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-17158000	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-53181000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	46291000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	88615000	usd
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-161632000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	134175000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	126306000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	52488000	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1528000	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	2377000	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2512000	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3782000	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends	773000	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends	569000	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends	0	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	138988000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	133034000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52488000	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.47
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.12
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.08
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.33
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.67
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.08
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12875000	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	12808000	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	16177000	shares
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	129506000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	147760000	usd
CY2022Q4	ahco	Right Of Use Assets Total RightOfUseAssetsTotal	135032000	usd
CY2021Q4	ahco	Right Of Use Assets Total RightOfUseAssetsTotal	165170000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	30001000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	31418000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	104394000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	120180000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	134395000	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	151598000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	2211000	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	15446000	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	6161000	usd
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	15578000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	37822000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	37043000	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	8246000	usd
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	33689000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	17758000	usd
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	14030000	usd
CY2022	us-gaap	Sublease Income SubleaseIncome	1380000	usd
CY2021	us-gaap	Sublease Income SubleaseIncome	1239000	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	0	usd
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	19905000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y2M12D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y8M12D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P3Y8M12D
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.039
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.038
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	34446000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	2318000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	28100000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	1567000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	24354000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	1566000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	17484000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	1074000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	12139000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	10000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	36089000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	152612000	usd
CY2022Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	6535000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	18217000	usd
CY2022Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	374000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	134395000	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	6161000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	37486000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	36510000	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	16176000	usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	42164000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	22543000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	91420000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	5423000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	22959000	usd
CY2022	ahco	Number Of Plans Administered By Others NumberOfPlansAdministeredByOthers	2	plan
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	4700000	usd
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2900000	usd
CY2022	ahco	Minimum Loss For Claim Under Medical Stop Loss Insurance MinimumLossForClaimUnderMedicalStopLossInsurance	300000	usd
CY2021	ahco	Minimum Loss For Claim Under Medical Stop Loss Insurance MinimumLossForClaimUnderMedicalStopLossInsurance	225000	usd
CY2020	ahco	Minimum Loss For Claim Under Medical Stop Loss Insurance MinimumLossForClaimUnderMedicalStopLossInsurance	175000	usd
CY2022Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	15600000	usd
CY2021Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	11700000	usd
CY2018Q2	ahco	Number Of Subsidiaries Participating In Agreement NumberOfSubsidiariesParticipatingInAgreement	1	subsidiary
CY2018Q2	ahco	Agreement Term AgreementTerm	P5Y
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-197000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	2356000	usd
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	5608000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	6930000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	8070000	usd
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3538000	usd
CY2022	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	6733000	usd
CY2021	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	10426000	usd
CY2020	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	9146000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	12205000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	22891000	usd
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-16587000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	5831000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-511000	usd
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-4514000	usd
CY2022	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	18036000	usd
CY2021	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	22380000	usd
CY2020	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-21101000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	24769000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	32806000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-11955000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.036
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.031
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.047
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.005
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.019
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.001
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.004
CY2022	ahco	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Liability EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiability	-0.037
CY2021	ahco	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Liability EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiability	-0.059
CY2020	ahco	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrant Liability EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrantLiability	-0.171
CY2022	ahco	Effective Income Tax Rate Reconciliation Change In Fair Value Of Nondeductible Contingent Consideration EffectiveIncomeTaxRateReconciliationChangeInFairValueOfNondeductibleContingentConsideration	0
CY2021	ahco	Effective Income Tax Rate Reconciliation Change In Fair Value Of Nondeductible Contingent Consideration EffectiveIncomeTaxRateReconciliationChangeInFairValueOfNondeductibleContingentConsideration	-0.012
CY2020	ahco	Effective Income Tax Rate Reconciliation Change In Fair Value Of Nondeductible Contingent Consideration EffectiveIncomeTaxRateReconciliationChangeInFairValueOfNondeductibleContingentConsideration	-0.044
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.026
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.003
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.017
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.086
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.011
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.017
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.003
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.253
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.172
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.058
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	37363000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	51115000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	262501000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	291331000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Investment In Subsidiaries DeferredTaxAssetsInvestmentInSubsidiaries	171000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Investment In Subsidiaries DeferredTaxAssetsInvestmentInSubsidiaries	4218000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1841000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	561000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	9207000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	6845000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	35459000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	32926000	usd
CY2022Q4	ahco	Deferred Tax Assets Start Up Organizational Costs DeferredTaxAssetsStartUpOrganizationalCosts	417000	usd
CY2021Q4	ahco	Deferred Tax Assets Start Up Organizational Costs DeferredTaxAssetsStartUpOrganizationalCosts	7580000	usd
CY2022Q4	ahco	Deferred Tax Assets Contract Liabilities DeferredTaxAssetsContractLiabilities	0	usd
CY2021Q4	ahco	Deferred Tax Assets Contract Liabilities DeferredTaxAssetsContractLiabilities	3041000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6101000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3801000	usd
CY2022Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	27918000	usd
CY2021Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	0	usd
CY2022Q4	ahco	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	35431000	usd
CY2021Q4	ahco	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	40683000	usd
CY2022Q4	ahco	Deferred Income Tax Assets Contingent Consideration DeferredIncomeTaxAssetsContingentConsideration	0	usd
CY2021Q4	ahco	Deferred Income Tax Assets Contingent Consideration DeferredIncomeTaxAssetsContingentConsideration	3541000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	817000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	817000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	417226000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	446459000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1812000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1812000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	415414000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	444647000	usd
CY2022Q4	ahco	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	34201000	usd
CY2021Q4	ahco	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	39760000	usd
CY2022Q4	ahco	Deferred Tax Liabilities Contingent Consideration DeferredTaxLiabilitiesContingentConsideration	2200000	usd
CY2021Q4	ahco	Deferred Tax Liabilities Contingent Consideration DeferredTaxLiabilitiesContingentConsideration	0	usd
CY2022Q4	ahco	Deferred Tax Liabilities Unrealized Gains DeferredTaxLiabilitiesUnrealizedGains	2950000	usd
CY2021Q4	ahco	Deferred Tax Liabilities Unrealized Gains DeferredTaxLiabilitiesUnrealizedGains	0	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	94277000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	100694000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	133628000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	140454000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	281786000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	304193000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1800000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1800000	usd
CY2022Q4	ahco	Operating Loss Carryforwards Interest Expense OperatingLossCarryforwardsInterestExpense	109900000	usd
CY2021Q4	ahco	Operating Loss Carryforwards Interest Expense OperatingLossCarryforwardsInterestExpense	0	usd
CY2022Q4	ahco	Historical Operating Loss Carryforwards Fully Limited From Ownership Changes HistoricalOperatingLossCarryforwardsFullyLimitedFromOwnershipChanges	1800000	usd
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	1947000	usd
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1947000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	2100000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4047000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	2670000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	78000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6639000	usd
CY2022Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	1600000	usd
CY2021Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	900000	usd
CY2019Q4	ahco	Shares Issued During Period Shares Shares Exchanged SharesIssuedDuringPeriodSharesSharesExchanged	3480466	shares
CY2019Q4	ahco	Tax Deductible Goodwill Basis Step Up TaxDeductibleGoodwillBasisStepUp	33600000	usd
	ahco	Shares Issued During Period Shares Shares Exchanged SharesIssuedDuringPeriodSharesSharesExchanged	31936305	shares
	ahco	Tax Deductible Goodwill Basis Step Up TaxDeductibleGoodwillBasisStepUp	1029600000	usd
CY2021	ahco	Tax Deductible Goodwill Basis Step Up TaxDeductibleGoodwillBasisStepUp	537900000	usd
CY2020	ahco	Tax Deductible Goodwill Basis Step Up TaxDeductibleGoodwillBasisStepUp	485700000	usd
CY2021	ahco	Shares Issued During Period Shares Shares Exchanged SharesIssuedDuringPeriodSharesSharesExchanged	13218758	shares
CY2020	ahco	Shares Issued During Period Shares Shares Exchanged SharesIssuedDuringPeriodSharesSharesExchanged	18167547	shares
CY2019Q4	ahco	Tax Receivable Agreement Percentage Savings Payable TaxReceivableAgreementPercentageSavingsPayable	0.85
CY2019Q4	ahco	Tax Receivable Agreement Percentage Savings Payable TaxReceivableAgreementPercentageSavingsPayable	0.85
CY2021	ahco	Liability For Payments Under Tax Receivable Agreement Increase Due To Shares Exchanged LiabilityForPaymentsUnderTaxReceivableAgreementIncreaseDueToSharesExchanged	146500000	usd
CY2020	ahco	Liability For Payments Under Tax Receivable Agreement Increase Due To Shares Exchanged LiabilityForPaymentsUnderTaxReceivableAgreementIncreaseDueToSharesExchanged	140400000	usd
CY2021	ahco	Deferred Tax Asset Attributable To Tax Receivable Agreement Increase Decrease DeferredTaxAssetAttributableToTaxReceivableAgreementIncreaseDecrease	164100000	usd
CY2020	ahco	Deferred Tax Asset Attributable To Tax Receivable Agreement Increase Decrease DeferredTaxAssetAttributableToTaxReceivableAgreementIncreaseDecrease	165200000	usd
CY2022	ahco	Liability For Payments Under Tax Receivable Agreement LiabilityForPaymentsUnderTaxReceivableAgreement	297400000	usd
CY2021	ahco	Liability For Payments Under Tax Receivable Agreement LiabilityForPaymentsUnderTaxReceivableAgreement	300300000	usd
CY2022	ahco	Income Expense Due To Changes In Tax Receivable Agreement Liability IncomeExpenseDueToChangesInTaxReceivableAgreementLiability	2900000	usd

Files In Submission

Name	View Source	Status
ahco-20221231_pre.xml	Edgar Link	unprocessable
0001628280-23-005590-index-headers.html	Edgar Link	pending
0001628280-23-005590-index.html	Edgar Link	pending
0001628280-23-005590.txt	Edgar Link	pending
0001628280-23-005590-xbrl.zip	Edgar Link	pending
ahco-20221231.htm	Edgar Link	pending
ahco-20221231.xsd	Edgar Link	pending
ahco-20221231xex231.htm	Edgar Link	pending
ahco-20221231xex311.htm	Edgar Link	pending
ahco-20221231xex312.htm	Edgar Link	pending
ahco-20221231xex32.htm	Edgar Link	pending
ahco-2022x12x31xex211.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
ahco-20221231_htm.xml	Edgar Link	completed
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ahco-20221231_cal.xml	Edgar Link	unprocessable
ahco-20221231_def.xml	Edgar Link	unprocessable
ahco-20221231_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AHCO
AdaptHealth Corp. Stock $ahco

2023 Q1 Form 10-K Financial Statement

#000162828023005590 Filed on February 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AHCO AdaptHealth Corp. Stock $ahco

2023 Q1 Form 10-K Financial Statement

#000162828023005590 Filed on February 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AHCO
AdaptHealth Corp. Stock $ahco